Sean Dalziel,Leticia M. Preza,Miroslav Rapta,Pierre-Jean Colson
申请号：
US15919678
公开号：
US20180200246A1
申请日:
2018.03.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention provides a crystalline sulfate salt of 3-endo-(8-{2-[cyclohexylmethyl-((S)-2,3-dihydroxy-propionyl)amino]ethyl}-8-aza-bicyclo[3.2.1]oct-3-yl)benzamide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with mu opioid receptor activity, and processes useful for preparing such crystalline salt forms.
